Order Article Reprints

von Amsberg G, Zilles M, Mansour W, Gild P, Alsdorf W, Kaune M, Böckelmann L, Hauschild J, Krisp C, Rohlfing T, et al. Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 2022; 23(23):14948. https://doi.org/10.3390/ijms232314948

von Amsberg, Gunhild, Mirjam Zilles, Wael Mansour, Philipp Gild, Winfried Alsdorf, Moritz Kaune, Lukas Böckelmann, Jessica Hauschild, Christoph Krisp, Tina Rohlfing, and et al. 2022. "Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer" International Journal of Molecular Sciences 23, no. 23: 14948. https://doi.org/10.3390/ijms232314948

von Amsberg, G., Zilles, M., Mansour, W., Gild, P., Alsdorf, W., Kaune, M., Böckelmann, L., Hauschild, J., Krisp, C., Rohlfing, T., Saygi, C., Alawi, M., Zielinski, A., Langebrake, C., Oh-Hohenhorst, S. J., Perner, S., Tilki, D., Schlüter, H., Graefen, M., ... Bokemeyer, C. (2022). Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences, 23(23), 14948. https://doi.org/10.3390/ijms232314948